Improving CRISPR-Cas technology for therapeutic applications
- 作者: Logvina N.A.1, Kopnin I.P.1, Aparin I.O.1, Zatsepin T.S.1,2
-
隶属关系:
- Center of Life Sciences, Skolkovo Institute of Science and Technology
- Chemistry Department, Lomonosov Moscow State University
- 期: 卷 14, 编号 3 (2019): Supplement
- 页面: 13-14
- 栏目: Articles
- ##submission.dateSubmitted##: 16.01.2023
- ##submission.datePublished##: 15.12.2019
- URL: https://genescells.ru/2313-1829/article/view/122052
- DOI: https://doi.org/10.23868/gc122052
- ID: 122052
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
全文:
作者简介
Nataliya Logvina
Center of Life Sciences, Skolkovo Institute of Science and Technology
Email: n.logvina@skoltech.ru
Ilya Kopnin
Center of Life Sciences, Skolkovo Institute of Science and Technology
Ilya Aparin
Center of Life Sciences, Skolkovo Institute of Science and Technology
Timofei Zatsepin
Center of Life Sciences, Skolkovo Institute of Science and Technology; Chemistry Department, Lomonosov Moscow State University
参考
补充文件
